
Consider buying the recent 10% pullback in Meta Platforms (META), as sharp valuation compression driven by overblown regulatory fears creates an attractive entry point.
Accumulate Hims & Hers Health (HIMS) on current market weakness to capture massive long-term upside from off-patent GLP-1 peptides ahead of the 2029–2030 patent expirations.
Take advantage of steep tech dips to build positions in AI infrastructure providers like Nebius Group (NBIS) and Iris Energy (IREN), which hold a competitive edge by owning their physical GPUs rather than acting as basic data center landlords.
Add high-performing growth stocks such as SoFi Technologies (SOFI), Sea Limited (SE), and Zeta Global (ZETA) to your portfolio, as their recent price drops are driven by broad macro volatility rather than their strong Q2 operational performance.
Prioritize direct spot Bitcoin (BTC) exposure over mining equities like Marathon Digital (MARA) or Cipher Mining (CIFR), as public crypto stocks remain burdened by equity market sell-offs and ongoing share dilution.

By @BeatTheDenominator